TOKYO, Mar 27 (Pulse News Wire) – Shionogi & CO.,LTD. (4507.T) has concluded a bridge loan agreement with Sumitomo Mitsui Banking Corporation to fund its additional investment in ViiV Healthcare Ltd.
The loan amount is ¥300.0 billion. The contract was signed, and the funds will be disbursed on March 31, 2026. Key details of the loan include: - Interest rate: Base rate plus spread - Final repayment date: March 26, 2027 - No collateral required This transaction complements another bridge loan previously disclosed on March 23, 2026 related to the acquisition of Edaravone therapy business from Nippon Pharma.
Together, these loans total ¥660.0 billion. Looking ahead, Shionogi plans to refinance the borrowed funds with long-term financing prior to their maturity. The impact on the fiscal year ending March 2026 is expected to be minor.
An assessment of the potential effects on the fiscal year ending March 2027 is ongoing; any significant developments will be promptly communicated.
🟢 Confidence: High AI-translated content.